Last Friday the board of the Stichting Katholieke Universiteit, together with the Executive Board of Radboud university medical center and the Executive Board of Radboud University, agreed on the ‘decision to separate’. Consequently, as of 1 January 2021 the demerger of Radboud University and Radboud university medical center will become effective.
Radboud university medical center and Radboud University are currently part of a single foundation: Stichting Katholieke Universiteit (SKU). The SKU board supervises both organizations. This will change as of 1 January 2021, when both organizations will establish their own foundation. Radboud University will remain in the present Stichting Katholieke Universiteit (SKU) and will be led by the present Executive Board. For Radboud university medical center the new Stichting Radboud universitair medisch centrum will be established, which will be led by the present Executive Board. In addition to their own boards, both foundations will each have their own supervisory board.
The ‘decision to separate’ was taken on 11 December 2020; an important step in the decision-making process. The decision is needed in order to sign the notarial act of separation on 31 December 2020 whereby the separation becomes a legal fact the next day. Daniël Wigboldus, chair of the Executive Board of Radboud University: “Both organizations will continue to work together intensively on, for example, research, education and campus-wide themes such as sustainability and campus development. We are going to strengthen that collaboration; we look forward to doing so.”
The right step at the right time
The separation is the right step at the right time for both organizations. Bertine Lahuis, chair of the Executive Board of Radboud university medical center: “As separate foundations, Radboud university medical center and Radboud University can respond more effectively to changes in our own complex surroundings. And we can also react better to social developments.”
Wim van der Meeren, chair of the SKU board, added: “Moreover, this enables better and more specific supervision because the members of the supervisory board of the foundation will have specific expertise for either Radboud University or Radboud university medical center. The members of the supervisory boards of both foundations will be announced in the first week of January.
Many colleagues of Radboud University and Radboud university medical center have been working hard behind the scenes to ensure that the separation on 1 January goes smoothly. This decision was preceded by months of careful preparations. The legal, financial and tax-based aspects of the separation were studied, the advisory and participational bodies were closely involved, and there was intense consultation between the SKU, Radboud University and Radboud university medical center with various involved organisations and partners.
Related news items
Willem Mulder appointed professor of Precision Medicine4 October 2022
Willem Mulder has been appointed professor of Precision Medicine at Radboud university medical center / Radboud University. He develops new drugs for immunotherapy against cancer, inflammation, rejection reactions and infectious diseases.read more
Immune cell becomes tumor cell by a molecular switch to higher lipid uptake Protein CD37 plays an important role in the development and prognosis of B-cell lymphoma19 September 2022
When B cells of the immune system no longer have the protein CD37 on their surface, they can change into tumor cells that form blood cancer. CD37 inhibits fat uptake in B cells. If this protein is missing, a tumor cell absorbs much more fat and therefore grows faster.read more